The Kidney, Nutrition, Obesity and Diabetes Study (KNOD) study section reviews applications on the epidemiology and genetic epidemiology of kidney, diabetes, obesity, urinary, gastrointestinal and liver diseases in human populations. The focus of interest can include molecular, genetic, epigenetic, pharmacologic, behavioral, environmental, microbiome, diet/nutrition, and physical activity. KNOD also reviews applications examining the development, progression and prognosis of these diseases/conditions. Applications that use animal or other models are excluded.


The List of Reviewers lists all present, whether permanent or temporary, to provide the full scope of expertise present on that date. Lists are posted 30 days before the meeting and are tentative, pending any last minute changes.

Review Dates

Membership Panel

The membership panel is a list of chartered members only.


  • Epidemiology studies that examine diet and nutrition, physical activity, environmental exposures and the microbiome on the disease conditions of interest to KNOD.
  • Studies that focus on the design, assessment and validation of methodologies to measure diet and physical activity. Physical activity methodologies include self-report and objective measures using technology such as accelerometers and GIS and audits of the built and physical environment. Diet methodologies include self-report, using technology or traditional paper.
  • Epidemiology and genetic epidemiology studies related to the determinants of bariatric surgery and outcomes.
  • Epidemiology studies related to the determinants, procurement and allocation of liver and kidney for transplantation and alloimmune outcomes.
  • Primary and secondary intervention including those evaluated by clinical trial (such as diet, physical activity and breastfeeding) with a focus on preventing onset or progression of disease, or improving clinical outcomes or prognosis of diseases or conditions.
  • Epidemiology research designs and approaches including cohort, case-control, prospective, longitudinal, retrospective, clinical trial, cross-sectional, surveillance, genetics, genome wide association studies (GWAS), epigenetics, genomics, gene-environment interactions, and molecular genetics.

Shared Interests and Overlaps

Applications focused on the epidemiology and genetic epidemiology of diabetes and obesity are assigned to KNOD. Applications focused on the etiology and treatment of metabolic disturbances associated with diabetes, gestational diabetes, and obesity are assigned to Clinical and Integrative Diabetes and Obesity (CIDO).

Psychosocial Risk and Disease Prevention (PRDP): Applications that focus on the primary prevention of obesity and diabetes may be assigned to either PRDP or KNOD. Applications that focus on the prevention of the development and/or progression of obesity/diabetes are assigned to KNOD while those that focus on social/psychosocial determinants of the onset and progression of obesity and social/psychosocial interventions to prevent or reduce risk are assigned to PRDP. PRDP would also review applications on the primary interventions of diet/nutrition and physical activity on obesity when the exposure is social/psychosocial in nature.

Genetics of Health and Disease (GHD): Applications related to genetics or epigenetics or genetic epidemiology of obesity, diabetic kidney, liver, gastrointestinal, and urinary conditions are assigned to KNOD. Applications focused on the discovery and development of genetic and genomic methodologies are assigned to GHD.

Infectious, Reproductive, Asthma and Pulmonary Conditions (IRAP): Both IRAP and KNOD review applications focused on environment exposures during pregnancy related to obesity. If obesity outcomes are assessed on the progeny or in children in later life, the application would be assigned to KNOD while applications that focus on the perinatal period and pregnancy related outcomes are reviewed in IRAP.